Hinge Health (NYSE:HNGE) Now Covered by Royal Bank of Canada

Royal Bank of Canada assumed coverage on shares of Hinge Health (NYSE:HNGE) in a research report report published on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $45.00 price target on the stock.

Several other research firms also recently issued reports on HNGE. Bank of America assumed coverage on Hinge Health in a research note on Monday. They issued a “buy” rating and a $42.00 price objective for the company. Barclays began coverage on shares of Hinge Health in a report on Monday. They set an “overweight” rating and a $43.00 price target for the company. Raymond James began coverage on shares of Hinge Health in a report on Monday. They set an “outperform” rating and a $45.00 price target for the company. Needham & Company LLC began coverage on shares of Hinge Health in a report on Monday. They set a “buy” rating and a $47.00 price target for the company. Finally, KeyCorp began coverage on shares of Hinge Health in a report on Monday. They set an “overweight” rating and a $45.00 price target for the company. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Hinge Health currently has an average rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Trading Up 5.2%

HNGE opened at $36.65 on Monday. Hinge Health has a twelve month low of $33.42 and a twelve month high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.